BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15389221)

  • 21. Prognostic importance of myonecrosis after percutaneous coronary interventions.
    Dangas G
    J Invasive Cardiol; 2001 Mar; 13(3):247-50; discussion 266-70. PubMed ID: 11231658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reoperative coronary artery bypass grafting: analysis of early and late outcomes.
    Di Mauro M; Iacò AL; Contini M; Teodori G; Vitolla G; Pano M; Di Giammarco G; Calafiore AM
    Ann Thorac Surg; 2005 Jan; 79(1):81-7. PubMed ID: 15620920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combining natriuretic peptides and necrosis markers in the assessment of acute coronary syndromes.
    de Lemos JA; Morrow DA
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S37-46. PubMed ID: 14564227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of myocardial enzyme release after coronary interventions.
    Kelly D; Arora R
    Catheter Cardiovasc Interv; 1999 Mar; 46(3):292-302. PubMed ID: 10348125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute coronary syndrome biomarkers: the need for more adequate reporting.
    Jaffe AS; Katus H
    Circulation; 2004 Jul; 110(2):104-6. PubMed ID: 15249513
    [No Abstract]   [Full Text] [Related]  

  • 26. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
    Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
    J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting.
    Shyu KG; Kuan PL; Cheng JJ; Hung CR
    Am Heart J; 1998 May; 135(5 Pt 1):862-7. PubMed ID: 9588418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of acute coronary syndromes.
    Tahiliani N; Trivedi A; Deshmukh HG
    N Engl J Med; 2002 Jan; 346(3):206-8. PubMed ID: 11797722
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnosis of acute coronary syndrome.
    Achar SA; Kundu S; Norcross WA
    Am Fam Physician; 2005 Jul; 72(1):119-26. PubMed ID: 16035692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors and prognostic value of myocardial injury following stent implantation.
    Ramírez-Moreno A; Cardenal R; Pera C; Pagola C; Guzmán M; Vázquez E; Fajardo A; Lozano C; Solís J; Gassó M
    Int J Cardiol; 2004 Nov; 97(2):193-8. PubMed ID: 15458683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac troponins and their current clinical application].
    Lafuente Gormaz C; Terrancle de Juan I; Broseta Viana L
    Med Clin (Barc); 2003 Mar; 120(10):389-94. PubMed ID: 12681105
    [No Abstract]   [Full Text] [Related]  

  • 32. Creatine kinase leaks, myocardial necrosis, and prognosis after percutaneous coronary interventions.
    Bittl JA
    Catheter Cardiovasc Interv; 1999 Mar; 46(3):303-4. PubMed ID: 10348126
    [No Abstract]   [Full Text] [Related]  

  • 33. [Comparative assessment of the prognostic value of four biochemical markers of myocardial damage after percutaneous coronary stenting].
    Centemero M; Sousa A; Staico R; Abizaid A; Feres F; Tanajura LF; Mattos LA; Chaves A; Pinto I; Sarteschi C; Paes A; Sousa JE
    Arq Bras Cardiol; 2004 Dec; 83 Spec No():53-8. PubMed ID: 15608990
    [No Abstract]   [Full Text] [Related]  

  • 34. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of cardiac troponin I versus T and creatine kinase MB after coronary artery bypass grafting in patients with and without perioperative myocardial infarction.
    Peivandi AA; Dahm M; Opfermann UT; Peetz D; Doerr F; Loos A; Oelert H
    Herz; 2004 Nov; 29(7):658-64. PubMed ID: 15580320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Images in cardiovascular medicine. Isolated right ventricular infarction resulting from occlusion of a nondominant right coronary artery.
    Gregory SA; Desai AS; Fifer MA
    Circulation; 2004 Nov; 110(20):e500-1. PubMed ID: 15545523
    [No Abstract]   [Full Text] [Related]  

  • 37. [Troponin as myocardial cell injury marker].
    de Godoy MF; Braile DM; Purini Neto J
    Arq Bras Cardiol; 1998 Oct; 71(4):629-33. PubMed ID: 10347942
    [No Abstract]   [Full Text] [Related]  

  • 38. Cardiac troponins in acute coronary syndromes.
    Haft JI; Saadeh SA
    N Engl J Med; 1997 Apr; 336(17):1257; author reply 1258-9. PubMed ID: 9121525
    [No Abstract]   [Full Text] [Related]  

  • 39. Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker.
    Okmen E; Kasikcioglu H; Sanli A; Uyarel H; Cam N
    J Invasive Cardiol; 2005 Feb; 17(2):63-7. PubMed ID: 15687525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Porto I; Van Gaal W; Banning A
    Eur Heart J; 2005 Oct; 26(20):2206; author reply 2206-7. PubMed ID: 16087650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.